DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Business Affairs Homepage

Canon elaborates on financial goals with Toshiba Medical in the fold 'Launching into the global health marker ... in one fell swoop'

Former Cleveland Clinic Innovations director pleads guilty to fraud Scheme cost the institution over $2.7 million

NuVasive files lawsuit against former vice chairman Alleges breach of fiduciary duties and violation of contractual obligations

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

Philips to halt production of external defibrillators in two U.S. facilities OEM looks ahead, calling consent decree 'consequence of past sins'

2017 AARC Congress: Focus on COPD For four days in Indianapolis, patients took center stage

Amazon may decide to sell prescription drugs online by Thanksgiving Supply chain and regulatory hurdles could make it more trouble than it's worth

Lynn O'Connor Vos Muscular Dystrophy Association appoints CEO

Philips inks 5-year maintenance and service agreement with Indonesian hospital group Covers equipment in 21 hospitals

GE opens its first European 3-D printing and design center in Sweden Plans to grow its additive business to $1B by 2020

Boston Scientific has agreed to acquire
Apama Medical for $300 million

Boston Scientific to acquire Apama Medical

by John Fischer , Staff Reporter
Boston Scientific Corporation has agreed to acquire Apama Medical Inc. for a sum of $300 million.

The acquisition of the privately-held, California-based company will allow Boston Scientific to expand its electrophysiology portfolio, combining its radiofrequency point-by-point solution with Apama’s single-shot balloon ablation technology for the treatment of atrial fibrillation (AF).

Story Continues Below Advertisement

Streamline Your Radiology Workflow with RamSoft's PowerServer RIS/PACS

The PowerServer RIS/PACS is a single database application, essential to reducing redundant work, limiting manual data entry, and increasing consistency throughout healthcare practices. Click to learn how it will help you improve patient care and more.



“Single-shot pulmonary vein isolation (PVI) ablation is a high growth market segment,” Joe Fitzgerald, president of rhythm management at Boston Scientific, told HCB News. “Our current electrophysiology (EP) portfolio includes a radiofrequency (RF) point-by-point solution, and the Apama technology, upon regulatory approval, will allow us to expand into the single-shot market segment, and ultimately bolster our entire EP portfolio.”

PVI is the current standard form of treatment in AF ablations and is performed using either point-by-point RF-based ablation or single-shot balloon-based ablation.

As part of the agreement, Boston Scientific will acquire Apama’s concept device, the Apama Radiofrequency (RF) Balloon Catheter System, which combines the primary benefits of RF point-by-point and balloon-based ablation approaches, allowing physicians to administer different amounts of energy and shorten procedure times.

Boston Scientific plans to integrate the RF balloon system with its RHYTHMIA HDx Mapping System, the only high density and high resolution map in the industry, to provide physicians with never before seen visualization of the heart during ablation procedures. It also will acquire intellectual property and 40 employees from Apama.

“The Apama RF Balloon System offers benefits to both patients and physicians as its initial clinical results have demonstrated that the technology meets the study endpoints of safety and efficacy, while also offering improvements to procedure efficiency,” Amr Salahieh, the CEO and president of Apama Medical, told HCB News.

The RHYTHMIA HDx Mapping System is available to consumers. The Apama RF Balloon Catheter System is still being studied and is not yet for sale.

An upfront cash transaction of $175 million has already been paid. A maximum of $125 million in contingent payments will be made between 2018 and 2020 based on successes in clinical and regulatory processes.

Completion of the acquisition is expected in the fourth quarter of 2017, subject to customary closing conditions.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED